IP Library Granted Patent US 7,618,786
Granted Patent B2
US 7,618,786 · App. 10/537,732 · Granted Nov 17, 2009

Method for identifying modulators of human orexin-2 receptor

Assignee: Janssen Pharmaceutica N.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,618,786
App. No.
10/537,732
Granted
Nov 17, 2009
Kind
B2
Abstract

The present invention provides a new method for identifying modulators of human orexin-2 receptor without utilizing recombinantly produced nucleic acid molecules encoding human orexin receptor protein. This method combines and utilizes known methods and cell lines selected for their natural expression of orexin-2 receptors to carry out the methods of the present invention. Exemplary methods of the present invention utilize PFSK-1 cells to produce non-recombinant human orexin-2 receptor protein.

Claims (10)

1. A method for identifying compounds that modulate human orexin-2 receptor activity, comprising:

a) combining a putative modulator of human orexin-2 receptor activity with human orexin-2 receptors contained within membranes of PFSK-1 cells non-recombinantly possessing the human orexin-2 receptor; and

b) measuring the effect of the modulator on activity of the human orexin-2 receptor.

2. The method of claim 1 , wherein the effect measured in step (b) is binding of the putative modulator to the orexin-2 receptors.

3. The method of claim 1 , wherein the effect measured in step (b) is competition of the putative modulator with a known ligand of the human orexin-2 receptor for binding to the receptors.

4. The method of claim 1 , wherein the effect measured in step (b) is modulation of a human orexin-2 receptor intracellular second messenger.

5. The method of claim 4 , wherein the intracellular second messenger is selected from a group consisting of cAMP, Ca ++ , and a reporter gene product.

6. The method of claim 5 , wherein the cells are transfected with a Gα-protein DNA construct.

7. The method of claim 5 , wherein the intracellular second messenger is Ca ++ , detected with a fluorescent Ca ++ indicator.

8. The method of claim 1 , adapted to distinguish the putative modulator as an agonist, antagonist or inverse agonist of the orexin-2 receptor.

Continuity (2)
Provisional Application 6043341100 · Dec 13, 2002
Related Publication 20060035285A1 · Feb 16, 2006